MedPath

Efficacy of IPL in acne

Not Applicable
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT201201178656N1
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
35
Inclusion Criteria

In our study inclusion criterions were the presence of at least 5 persistent erythematous macules on every side of the patients' face and these macules should be complication of inflammatory acne lesions and these macules should be persistent even with receiving at least two months of standard treatments. Exclusion criterions were oral retinoid use from 6 months before the study, necessity of systemic treatments (i.e. nodulocystic or scarring acne), history of keloid, vitiligo, drugs that exacerbate or remit acne lesions, history of skin cancer, photosensitivity disorders and history of poor wound healing such as diabetes mellitus

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Persistent erythematous macules of facial acne. Timepoint: Before the study, before every IPL session, 1 and 3 months after last IPL session. Method of measurement: Counting and photography.
Secondary Outcome Measures
NameTimeMethod
Erythema. Timepoint: One week after every IPL session. Method of measurement: Questionnaire.;Pain. Timepoint: One week after every IPL session. Method of measurement: Questionnaire.;Photosensitivity. Timepoint: One week after every IPL session. Method of measurement: Questionnaire.;Swelling. Timepoint: One week after every IPL session. Method of measurement: Questionnaire.;Blister. Timepoint: One week after every IPL session. Method of measurement: Questionnaire.;Crusting. Timepoint: One week after every IPL session. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath